- Home
- YSXT vs ADVM Comparison
YSXT vs ADVM Comparison
Compare YSXT & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YSXT
- ADVM
- Stock Information
- Founded
- YSXT 2011
- ADVM 2006
- Country
- YSXT China
- ADVM United States
- Employees
- YSXT N/A
- ADVM N/A
- Industry
- YSXT Automotive Aftermarket
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- YSXT Consumer Discretionary
- ADVM Health Care
- Exchange
- YSXT Nasdaq
- ADVM Nasdaq
- Market Cap
- YSXT 87.9M
- ADVM 98.0M
- IPO Year
- YSXT 2024
- ADVM 2014
- Fundamental
- Price
- YSXT $2.85
- ADVM $4.26
- Analyst Decision
- YSXT
- ADVM Strong Buy
- Analyst Count
- YSXT 0
- ADVM 6
- Target Price
- YSXT N/A
- ADVM $27.83
- AVG Volume (30 Days)
- YSXT 7.5K
- ADVM 143.5K
- Earning Date
- YSXT 02-24-2025
- ADVM 05-08-2025
- Dividend Yield
- YSXT N/A
- ADVM N/A
- EPS Growth
- YSXT N/A
- ADVM N/A
- EPS
- YSXT 0.18
- ADVM N/A
- Revenue
- YSXT $66,143,276.00
- ADVM $1,000,000.00
- Revenue This Year
- YSXT N/A
- ADVM N/A
- Revenue Next Year
- YSXT N/A
- ADVM $1,162.55
- P/E Ratio
- YSXT $14.77
- ADVM N/A
- Revenue Growth
- YSXT 21.23
- ADVM N/A
- 52 Week Low
- YSXT $2.06
- ADVM $3.52
- 52 Week High
- YSXT $6.27
- ADVM $14.16
- Technical
- Relative Strength Index (RSI)
- YSXT N/A
- ADVM 44.68
- Support Level
- YSXT N/A
- ADVM $4.76
- Resistance Level
- YSXT N/A
- ADVM $5.23
- Average True Range (ATR)
- YSXT 0.00
- ADVM 0.51
- MACD
- YSXT 0.00
- ADVM -0.12
- Stochastic Oscillator
- YSXT 0.00
- ADVM 24.69
About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.